drugset

drugset / Trial / NCT02745860

Comparison of Two Dose Strengths of Selexipag in Healthy Adults

NCT02745860 ↗

Phase 1 Completed 20 enrolled Actelion

RandomizedCrossoverOpen-labelOther

Summary

Clinical study in healthy adult subjects to compare the adult tablet of selexipag with the tablet developed for children.

Timeline

Start: 2016-06
Primary completion: 2016-06
Completion: 2016-06

Publications

Boehler M, Bruderer S, Ulc I, Dingemanse J. Biocomparison Study of Adult and Paediatric Dose Strengths of the Prostacyclin Receptor Agonist Selexipag. Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):115-120. doi: 10.1007/s13318-017-0424-z.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Selexipag	Small molecule	200 ug	Oral

Indications

No indication recorded.